Muriel Licour

Suggest Changes
Learn More
Primary percutaneous coronary intervention (PCI) is the treatment of choice for patients presenting with acute ST-segment elevation myocardial infarction (STEMI). However, if catheterization(More)
AIMS To describe international patterns and opportunities for improvement of pre- and in-hospital care of patients hospitalized for acute coronary syndromes (ACS), with special focus on(More)
AIMS A reliable prediction tool is needed to identify acute coronary syndrome (ACS) patients with high mortality risk after their initial hospitalization. METHODS EPICOR (long-tErm follow uP of(More)
BACKGROUND The mechanism underlying statin-induced event reduction in patients with acute coronary syndrome remains unclear. AIMS To assess the efficacy of rosuvastatin 20mg versus atorvastatin 80(More)
Many patients at high cardiovascular risk still fail to achieve recommended LDL-C goals. Showing evidence of a difference between two statins at the same dose can significantly contribute to(More)
G. Pasello1, V. Polo2, S. Frega2, M. Lorenzi3, S. Indraccolo4, M. Fassan5, L. Bonanno1, N. Nannini6, P.F. Conte2, F. Calabrese6. 1Medical and experimental oncology department, Medical Oncology 2,(More)